Titre:
  • Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
Auteur:Goss, Paul E; Ingle, James N; Pater, Joseph L; Martino, S; Robert, Nicholas J; Muss, Hyman B; Piccart-Gebhart, Martine; Castiglione, Monica; Shepherd, L; Pritchard, Kathleen; Livingston, Robert; Davidson, Nancy E; Norton, Larry; Perez, Edith A; Abrams, Jeffrey S; Cameron, David A; Palmer, Michael J; Tu, Dongsheng
Informations sur la publication:Journal of clinical oncology, 26, 12, page (1948-1955)
Statut de publication:Publié, 2008-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Aged, 80 and over
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- adverse effects
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant
Cohort Studies
Disease-Free Survival
Double-Blind Method
Drug Administration Schedule
Female
Humans
Middle Aged
Neoplasms, Hormone-Dependent -- drug therapy
Nitriles -- administration & dosage
Nitriles -- adverse effects
Placebos
Postmenopause
Tamoxifen -- administration & dosage
Treatment Outcome
Triazoles -- administration & dosage
Triazoles -- adverse effects
Note générale:Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2007.11.6798
info:pii/JCO.2007.11.6798
info:pmid/18332475